Publicaties

VanDerNagel JEL, Duijvenbode vanN, Ruedrich S., Ayu A.P., Schellekens A.F.A..  2018.  The Perception of Substance Use Disorder Among Clinicians, Caregivers and Family Members of Individuals With Intellectual and Developmental Disabilities. Journal of mental health research in intellectual disabilities. 11:54-68.

Duijvenbode vanN, Didden R, VanDerNagel JEL, Korzilius HPLM, Engels RCME.  2018.  The relationship between drinking motives and interpretation bias in problematic drinkers with mild to borderline intellectual disability. Journal of Intellectual & Developmental Disability. 43(2):125-136.

Kraan AEM, Dijkstra BAG, Markus W.  2018.  Treatment delivery of the community reinforcement approach in outpatient addiction treatment.. Eval Program Plann. 70:61-66.

Dijkstra BAG, Beurmanjer H., Kamal RM, Schellekens A.  2017.  De behandeling van GHB-afhankelijkheid. Medisch Contact.

de Weert-van Oene GH, Markus W, Kissane DW, DeJong CA.  2017.  Demoralization in patients with substance use and co-occurring psychiatric disorders. . Journal of Dual Diagnosis. 13(2)

De Weert GH, Markus W, Kissane DW, DeJong CA.  2017.  Demoralization in Patients With Substance Use and Co-Occurring Psychiatric Disorders.. J Dual Diagn. 13(2):136-143.

Dijkstra BAG, Kamal R, van Noorden MS, de Haan H, Loonen AJM, DeJong CA.  2017.  Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project. Drug Alcohol Depend. 170:164-173.

Luijten M, Schellekens A, Kuhn S, Machielse MW, Sescousse G.  2017.  Disruption of Reward Processing in Addiction : An Image-Based Meta-analysis of Functional Magnetic Resonance Imaging Studies. Jama Psychiatry. 74(4):387-398.

Martial LC, Aarnoutse RE, Mulder M, Schellekens A, Brüggemann RJM, Burger DM, Schene AH, Batalla A.  2017.  Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring.. Eur Neuropsychopharmacol. 27(3):205-216.

Kiewik M, VanDerNagel JEl, Engels RCME, DeJong CA.  2017.  The efficacy of an e-learning prevention program for substance use among adolescents with intellectual disabilities: A pilot study.. Res Dev Disabil. 63:160-166.

Markus W, Hornsveld H.  2017.  EMDR interventions in addiction.. Journal of EMDR Practice and Research. 11(1):27.

Qurishi R., Markus W, Habra M.J.M., Bressers B., DeJong CA.  2017.  EMDR therapy reduces intense treatment-resistant cravings in a case of gamma-Hydroxybutyric acid addiction. Journal of EMDR Practice and Research. 11(1)

Markus W, Geurink M., S. Gi TPian, De Jongh A., Kranenburg L..  2017.   Eye Movement Desensitization and Reprocessing (EMDR) therapie.. Databank(en): Langdurige GGZ..

Dijkstra BAG, van Oort M.  2017.  Handleiding Detoxificatie van psychoactieve middelen. Verantwoord ambulant of intramuraal detoxificeren. Resultaten Scoren.

Verbrugge CAG, Stollenga M..  2017.  Herstelondersteuning in Nederland: een stand van zaken. Naar een herstelondersteunende verslavingszorg. :18.

de Jong MArts-, DeJong CA, Hermens RP, Kissane DW, Massuger LM, Hoogerbrugge N, Prins JB, deHullu JA.  2017.  High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life.. J Psychosom Obstet Gynaecol. :1-9.

van Lier H.G., Pieterse M.E., Schraagen J.M.C., Postel M.G., Vollenbroek-Hutten M.M.R., de Haan H.A., Noordzij M.L..  2017.  Identifying viable theoretical frameworks with essential parameters for real-time and real world alcohol craving research: a systematic review of craving models. . Addiction Research & Theory.

Luteijn I., Didden R, VanDerNagel JEL.  2017.  Individuals with Mild Intellectual Disability or Borderline Intellectual Functioning in a Forensic Addiction Treatment Center: Prevalence and Clinical Characteristics, Advances in Neurodevelopmental Disorders. Advances in Neurodevelopmental Disorders. :240-251.

Kiewik M, VanDerNagel JEl, Engels RCME, DeJong CA.  2017.  Intellectually disabled and addicted: a call for evidence based tailor-made interventions.. Addiction. 112(11):2067-2068.

van Oosterhout e, DeFuentes-Merillas L, Verbrugge CAG, de Feijter A, Franzek E.  2017.  Langdurig gedwongen ketenzorg onder onafhankelijke regie: een oplossing voor complexe casuistiek. Tijdschrift voor Verslaving. DOI 10.1007/s12501-017-0119-9

Montfoort K, de Weert-van Oene GH, Beurmanjer H, Koekkoek B.  2017.  Late-onset alcohol dependence: patient-reported problems. Addiction Research & Theory . 25(2)

Schellekens A, Luijten M, Sescousse G.  2017.  Neuroimaging meta-analyses across psychiatric disorders: challenges and promises. Jama Psychiatry.

Chye Y, Solowij N, Suo C, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S, Lorenzetti V, Yücel M.  2017.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.. Psychopharmacology (Berl).

Kamal RM, van Noorden MS, Wannet W, Beurmanjer H, Dijkstra BAG, Schellekens A.  2017.  Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs. 31(1):51-64.

van Noorden MS, Kamal R, Beurmanjer H, Dijkstra BAG, Schellekens AFA.  2017.  [Reaction on 'Hypernatremia caused by treatment with GHB obtained via a doctor's prescription'].. Tijdschr Psychiatr. 59(3):195-196.